SUPERNOVARTIS READY TO IMPLOSEThere is monstruosus bearish pattern on resistance for a double top for novartis.
My conservative target are there
BIO
NOVNEE trade ideas
Novartis Pharma going up on MACDNVS Novartis owns or makes a slew of pharmacopial needs for a variety of medical needs.
Little dip during recent pullback.
Watching Friday ads, all brand names no companies. All Novartis or made for another company by Novartis.
Novartis almost a buyPharmaceutical stocks represents a defensive asset when a positive market cycle is about to finish or when it is foreseen a cycle less positive than the previous one. In such context pharma stocks should have an advantage because of inelastic demand for such goods.
Novartis ($NVS,$NOVN) is one of the candidate to break up as the price is moving in a triangle since 2015. the stock doesn't not have an high volatility as other stocks but is one of the main represented of INDEX STOCK HEALTH CARE. There are nice technical indications on the chart that a breakout might happen in the next weeks. At the moment I am expecting a price pullback, where at the end it will be possible to go for an entry long.
Conclusions
At the moment price is consolidating and some other days to reduce RSI value will be needed. It's possible either to open positions at the end of the pullback or when price breaks out the downtrend (2015). Possibility to have it in CHF or $.
NVS Detected possible FDA approval!!!NVS: novartis ag
2018-06-19 16:02:05
Detected possible FDA approval
Currently Neutral on NVS but it can bounce nicely off trend lineI see this going down a bit to $72 but growing after that. Currently a WATCH.
NVS Detected possible FDA approval!!!NVS: novartis ag
2018-05-11 18:35:56
Detected possible FDA approval
$NVS retrace to .382 and weekly 10 EMA $NVS retrace to .382 and weekly 10 EMA ... reversal today pre market.
Novartis Ready For A Fresh Leg HigherNovartis has corrected about 7% towards and below its 200day moving average, and is coming back. A close above 78.35 today, would confirm that. Momentum indicators were a little oversold and are bouncing.
Stop at 77.50
Target zone: 82.80 - 84.00
NVS plan to CALLNVS plan to CALL due to the break up of down trend line. Consecutive targets are as of each resistant lines.
Novartis - Long planThe price got out of its ranging bound. The lagging span broke the Kijun and had just bounced on the range rectangle before. We may expect the price to lateralize a bit before the earnings and then, if they are positive, to see an uptrend that would make it reach the higher part of the cloud. A retracement after benefits are taken would provide a good entry point for a long, ideally supported by the SSB and with a target given by a flat Kijun level, 80 or 82.
RSI is bullish and if it manages to stay above 60, the scenario would have more weight.
